白细胞介素-40及产生白细胞介素-40的细胞在原发性格林巴利综合征患者淋巴细胞浸润的唾液腺中的可能作用
本研究纳入29例原发性格林巴利综合征(pSS)患者和24例对照,检测白细胞介素(IL)-40在pSS及pSS相关淋巴瘤中的表达。结果显示IL-40在pSS淋巴细胞浸润的小唾液腺中显著升高,与灶性评分及IL-4、转化生长因子-β表达相关,血清IL-40水平与EULAR格林巴利综合征疾病活动指数评分相关,B细胞是IL-40的主要来源,重组IL-40可促使患者外周血单个核细胞释放促炎细胞因子,pSS相关淋巴瘤的腮腺中IL-40表达亦增高。作者认为IL-40可能参与pSS发病及pSS相关淋巴瘤。
要点
- pSS患者淋巴细胞浸润的小唾液腺中IL-40显著升高,且与灶性评分及IL-4、TGF-β表达相关。
- pSS患者血清IL-40升高,其水平与EULAR格林巴利综合征疾病活动指数评分相关。
- B细胞是pSS患者组织和外周IL-40的主要来源,重组IL-40可促使患者PBMCs释放促炎细胞因子。
核心结论
- 作者认为IL-40可能在pSS发病及pSS相关淋巴瘤中发挥作用。
研究设计与样本
- 研究纳入29例pSS患者和24例对照,获取患者与对照的小唾液腺活检及pSS相关淋巴瘤的腮腺活检。
- 对小唾液腺行TaqMan实时PCR定量基因表达分析和IL-40免疫组化,用流式细胞术和免疫荧光确定IL-40的细胞来源。
- 用ELISA检测血清IL-40浓度,用流式细胞术确定IL-40的细胞来源,并用重组IL-40(rIL-40)进行体外实验检测其对PBMCs细胞因子产生的影响。
主要发现
- IL-40在pSS患者淋巴细胞浸润的小唾液腺中显著升高,并与灶性评分及IL-4和转化生长因子-β表达相关。
- pSS患者血清IL-40升高,其水平与EULAR格林巴利综合征疾病活动指数评分相关。
- 患者B细胞在组织和外周水平均为IL-40的主要来源。
- 患者PBMCs体外暴露于rIL-40后释放促炎细胞因子,具体为B细胞和T-CD8+细胞释放干扰素-γ,T-CD4+和T-CD8+细胞均释放肿瘤坏死因子-α和IL-17。
- pSS相关淋巴瘤的腮腺中IL-40表达亦增高,且在pSS患者中性粒细胞中证实了IL-40驱动的NETosis。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aim of this study was to investigate the expression of interleukin (IL)-40, a new cytokine associated with B cells homoeostasis and immune response, in primary Sjögren syndrome (pSS) and in pSS-associated lymphomas. METHODS: 29 patients with pSS and 24 controls were enrolled. Minor salivary gland (MSG) biopsies from patients, controls and parotid gland biopsies from pSS-associated lymphoma were obtained. Quantitative gene expression analysis by TaqMan real-time PCR and immunohistochemistry for IL-40 were performed on MSG. MSG cellular sources of IL-40 were determined by flow-cytometry and immunofluorescence. Serum concentration of IL-40 was assessed by ELISA and cellular sources of IL-40 were determined by flow-cytometry. An in vitro assay with recombinant IL-40 (rIL-40) was performed to detect the effect on cytokine production from peripheral blood mononuclear cells (PBMCs). RESULTS: IL-40 was significantly increased in the lymphocytic infiltrated MSG of patients with pSS and correlated with focus score and with IL-4 and transforming growth factor-β expression. In addition, IL-40 was increased in the serum of pSS and its levels correlated with the EULAR Sjögren's Syndrome Disease Activity Index score. B cells from patients were shown to be the major source of IL-40 at both tissue and peripheral level. PBMCs from patients, exposed to rIL-40 in vitro, released proinflammatory cytokines, specifically interferon-γ from B cells and T-CD8+ and tumour necrosis factor-α and IL-17 from both T-CD4+ and T-CD8+. IL-40 expression in parotid glands of pSS-associated lymphomas was also increased. Moreover, IL-40-driven NETosis was evidenced in neutrophils obtained from pSS. CONCLUSION: Our results suggest that IL-40 may play a role in pSS pathogenesis and pSS-associated lymphomas.
引用
- Guggino G, Rizzo C, Mohammadnezhad L, et al. Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome. RMD Open. 2023. PMID: 37137540. doi:10.1136/rmdopen-2022-002738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。